Boston, Christopher

Scholar Rock (United States)

1 paper on CoChatORCID 0000-0003-4403-2832

Most cited papers

Verified
Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape
Martin, C. J., Datta, A., Littlefield, C., Kalra, A., Chapron, C., Wawersik, S., Dagbay, K. B., Brueckner, C. T., Nikiforov, A., Danehy, F. T., et al. (2020) · Science Translational Medicine
Cancer Immunotherapy and BiomarkersTGF-β signaling in diseases
Cited by 224

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free